AEHR Should I Buy
-
$
0.000
0.000(0.000%)
At close0.000(0.000%)Aft-market
ET
Aehr Test Systems (AEHR) is not a strong buy at the moment for a beginner investor with a long-term strategy. The stock has experienced significant price declines recently, and while analysts have raised their price targets and highlighted potential growth in AI-related markets, the company's financial performance and insider selling trends raise concerns. The lack of recent positive trading signals and no significant news catalysts further support a cautious approach.
The stock is currently in a bearish trend with the MACD histogram below 0 and negatively expanding. The RSI is at 37.948, indicating neutral momentum. Moving averages are converging, and the stock is trading near its key support level (S1: 34.185).
Analysts have raised price targets significantly, citing potential growth in AI-related orders and a larger total addressable market for burn-in tools. The firm is expected to see a revenue ramp in FY27.
The stock has dropped significantly in regular trading (-11.43%) and continues to face insider selling, which has increased by 252.27% over the last month. Financial performance in Q2 2026 shows a revenue decline of -26.53% YoY and a drop in gross margin by -35.85%.
In Q2 2026, revenue dropped by -26.53% YoY to $9.88M. Net income improved to -$3.23M, up 214.20% YoY, and EPS increased to -0.11, up 266.67% YoY. Gross margin declined significantly to 25.75%, down -35.85% YoY.
Analysts have shown optimism with Lake Street raising the price target to $50 from $29 and William Blair estimating a fair value between $50 and $70. However, Craig-Hallum previously lowered the price target to $21 due to weaker-than-expected results and guidance.
